WHO guidelines for treatment of tuberculosis: the missing links.
Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis.
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. pharmacist_atif@yahoo.com
Muhammad
M
Atif
Syed Azhar Syed
SA
Sulaiman
Asrul Akmal
AA
Shafie
Irfhan
I
Ali
Mohamed Azmi
MA
Hassali
Fahad
F
Saleem
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005076:Exanthema / Q000139:chemically induced / Q000188:drug therapy*; D017408:Guidelines as Topic; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D011788:Quality of Life / Q000523:psychology; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000523:psychology*; D014944:World Health Organization
D000995:Antitubercular Agents; D006633:Histamine Antagonists